» Articles » PMID: 19025984

Movement Disorder Society-sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results

Abstract

We present a clinimetric assessment of the Movement Disorder Society (MDS)-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS). The MDS-UDPRS Task Force revised and expanded the UPDRS using recommendations from a published critique. The MDS-UPDRS has four parts, namely, I: Non-motor Experiences of Daily Living; II: Motor Experiences of Daily Living; III: Motor Examination; IV: Motor Complications. Twenty questions are completed by the patient/caregiver. Item-specific instructions and an appendix of complementary additional scales are provided. Movement disorder specialists and study coordinators administered the UPDRS (55 items) and MDS-UPDRS (65 items) to 877 English speaking (78% non-Latino Caucasian) patients with Parkinson's disease from 39 sites. We compared the two scales using correlative techniques and factor analysis. The MDS-UPDRS showed high internal consistency (Cronbach's alpha = 0.79-0.93 across parts) and correlated with the original UPDRS (rho = 0.96). MDS-UPDRS across-part correlations ranged from 0.22 to 0.66. Reliable factor structures for each part were obtained (comparative fit index > 0.90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD.

Citing Articles

Non-motor fluctuations in Parkinson's disease: frequency and clinical correlate.

Mujahid B, Holla V, Kamble N, Yadav R, Pal P, Mahale R J Neural Transm (Vienna). 2025; .

PMID: 40082320 DOI: 10.1007/s00702-025-02908-0.


Contribution of fatigue experienced by Parkinson's Disease patients on caregiver burden.

Landolfo S, Urso D, Santoro C, Batzu L, Gnoni V, Giugno A J Neurol. 2025; 272(4):264.

PMID: 40072620 DOI: 10.1007/s00415-025-12962-z.


Dopaminergic modulation and dosage effects on brain state dynamics and working memory component processes in Parkinson's disease.

Lee B, Young C, Cai W, Yuan R, Ryman S, Kim J Nat Commun. 2025; 16(1):2433.

PMID: 40069154 PMC: 11897313. DOI: 10.1038/s41467-025-56660-w.


Comparing manual and automated methods for calculating speaking rate in Parkinson's disease.

Arzbecker L, Stipancic K, Greenlee J, Tjaden K JASA Express Lett. 2025; 5(3).

PMID: 40067083 PMC: 11905113. DOI: 10.1121/10.0036021.


Cueing-assisted gamified augmented-reality gait-and-balance rehabilitation at home for people with Parkinson's disease: protocol of a pragmatic randomized controlled trial implemented in the clinical pathway.

Geerse D, Hoogendoorn E, van Doorn P, van Bergem J, van Dam A, Hardeman L Front Neurol. 2025; 16:1512409.

PMID: 40066314 PMC: 11891067. DOI: 10.3389/fneur.2025.1512409.